Search Results - "Ohara, Yoshiaki"

Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer by Sekikawa, Akira, Fukui, Hirokazu, Sada, Ryota, Fukuhara, Manabu, Marui, Saiko, Tanke, Gensho, Endo, Masatsugu, Ohara, Yoshiaki, Matsuda, Fumihiro, Nakajima, Jun, Henmi, Shinichiro, Saito, Sumio, Tsumura, Takehiko, Maruo, Takanori, Kimura, Toru, Osaki, Yukio

“…Background The significance of gastric xanthelasma in relation to gastric cancer still remains unclear. We investigated whether gastric xanthelasma would be a…”
Get full text

Cold snare polypectomy reduced delayed postpolypectomy bleeding compared with conventional hot polypectomy: a propensity score-matching analysis by Yamashina, Takeshi, Fukuhara, Manabu, Maruo, Takanori, Tanke, Gensho, Marui, Saiko, Sada, Ryota, Taki, Mio, Ohara, Yoshiaki, Sakamoto, Azusa, Henmi, Shinichiro, Sawai, Yugo, Saito, Sumio, Nishijima, Norihiro, Nasu, Akihiro, Komekado, Hideyuki, Sekikawa, Akira, Asada, Masanori, Tumura, Takehiko, Kita, Ryuichi, Kimura, Toru, Osaki, Yukio

“…Abstract Background and study aims Cold snare polypectomy (CSP) for small colorectal polyps has lower incidence of adverse events, especially delayed…”
Get full text

Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma by Takeda, Haruhiko, Nishikawa, Hiroki, Iguchi, Eriko, Ohara, Yoshiaki, Sakamoto, Azusa, Saito, Sumio, Nishijima, Norihiro, Nasu, Akihiro, Komekado, Hideyuki, Kita, Ryuichi, Kimura, Toru, Osaki, Yukio

“…Aim To examine the effect of branched‐chain amino acid (BCAA) therapy for patients with unresectable hepatocellular carcinoma (HCC) treated with sorafenib…”
Get full text

Transcatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma: clinical outcome and safety in elderly patients by Nishikawa, Hiroki, Kita, Ryuichi, Kimura, Toru, Ohara, Yoshiaki, Takeda, Haruhiko, Sakamoto, Azusa, Saito, Sumio, Nishijima, Norihiro, Nasu, Akihiro, Komekado, Hideyuki, Osaki, Yukio

“…The aim of our study was to compare clinical outcomes between elderly patients aged ≥75 years (elderly group, n=66) with intermediate hepatocellular carcinoma…”
Get full text

A case of HIV-associated lymphoproliferative disease that was successfully treated with highly active antiretroviral therapy by Fujita, Haruyuki, Nishikori, Momoko, Takaori-Kondo, Akifumi, Yoshinaga, Noriyoshi, Ohara, Yoshiaki, Ishikawa, Takayuki, Haga, Hironori, Uchiyama, Takashi

“…We report a case of a 41-year-old male with human immunodeficiency virus (HIV)-associated lymphoproliferative disease (LPD) who was successfully treated with…”
Get full text

Simultaneous occurrence of inflammatory bowel disease and myelodysplastic syndrome due to chromosomal abnormalities in bone marrow cells by Nakamura, Fumiyasu, Watanabe, Tomohiro, Hori, Kimiko, Ohara, Yoshiaki, Yamashita, Kouhei, Tsuji, Yoshihisa, Ueda, Yoshihide, Mikami, Sakae, Nakase, Hiroshi, Chiba, Tsutomu

“…Although chromosomal abnormalities in bone marrow (BM) cells, such as trisomy 8, are risk factors for the development of inflammatory bowel diseases (IBD) as…”
Get more information

Proposal of the performance status combined Japan Integrated Staging system in hepatocellular carcinoma complicated with cirrhosis by NISHIKAWA, HIROKI, KITA, RYUICHI, KIMURA, TORU, ENDO, MASATSUGU, OHARA, YOSHIAKI, SAKAMOTO, AZUSA, SAITO, SUMIO, NISHIJIMA, NORIHIRO, NASU, AKIHIRO, KOMEKADO, HIDEYUKI, OSAKI, YUKIO

“…The present study examined the prognostic ability of our proposed performance status combined Japan Integrated Staging (PS-JIS) system in hepatocellular…”
Get full text

Clinical implication of performance status in patients with hepatocellular carcinoma complicating with cirrhosis by Nishikawa, Hiroki, Kita, Ryuichi, Kimura, Toru, Ohara, Yoshiaki, Sakamoto, Azusa, Saito, Sumio, Nishijima, Norihiro, Nasu, Akihiro, Komekado, Hideyuki, Osaki, Yukio

“…The aims of our study were to elucidate the relationship between baseline characteristics of hepatocellular carcinoma (HCC) patients complicating with liver…”
Get full text

Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma by NISHIKAWA, HIROKI, OSAKI, YUKIO, KITA, RYUICHI, KIMURA, TORU, OHARA, YOSHIAKI, TAKEDA, HARUHIKO, SAKAMOTO, AZUSA, SAITO, SUMIO, NISHIJIMA, NORIHIRO, NASU, AKIHIRO, KOMEKADO, HIDEYUKI, NISHIGUCHI, SHUHEI

“…The aim of the present study was to compare clinical outcomes in patients with intermediate-stage hepatocellular carcinoma (HCC) who underwent the following…”
Get full text

Clinical efficacy of non-transplant therapies in patients with hepatocellular carcinoma with Child-Pugh C liver cirrhosis by Nishikawa, Hiroki, Kita, Ryuichi, Kimura, Toru, Ohara, Yoshiaki, Takeda, Haruhiko, Sakamoto, Azusa, Saito, Sumio, Nishijima, Norihiro, Nasu, Akihiro, Komekado, Hideyuki, Osaki, Yukio

“…To compare clinical outcome in patients with Child-Pugh C hepatocellular carcinoma (HCC) treated with non-transplant therapies and those treated with best…”
Get full text

Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: Propensity score matching analysis by NISHIKAWA, HIROKI, KITA, RYUICHI, KIMURA, TORU, OHARA, YOSHIAKI, TAKEDA, HARUHIKO, SAKAMOTO, AZUSA, SAITO, SUMIO, NISHIJIMA, NORIHIRO, NASU, AKIHIRO, KOMEKADO, HIDEYUKI, OSAKI, YUKIO

“…We examined whether supplementation of branched-chain amino acid (BCAA) granules in an early stage of underlying liver disease (pretreatment serum albumin…”
Get full text

Hyponatremia in hepatocellular carcinoma complicating with cirrhosis by Nishikawa, Hiroki, Kita, Ryuichi, Kimura, Toru, Ohara, Yoshiaki, Sakamoto, Azusa, Saito, Sumio, Nishijima, Norihiro, Nasu, Akihiro, Komekado, Hideyuki, Osaki, Yukio

“…We aimed to investigate the effect of serum sodium level on survival in hepatocellular carcinoma (HCC) patients complicating with liver cirrhosis (LC). A total…”
Get full text

Percutaneous Radiofrequency Ablation Therapy for Recurrent Hepatocellular Carcinoma by NISHIKAWA, Hiroki, OSAKI, Yukio, KIMURA, Toru, IGUCHI, Eriko, TAKEDA, Haruhiko, OHARA, Yoshiaki, SAKAMOTO, Azusa, HATAMARU, Keiichi, SAITO, Sumio, NASU, Akihiro, KITA, Ryuichi

“…To compare the overall survival (OS) in patients without recurrent hepatocellular carcinoma (HCC) after initial radiofrequency ablation (RFA) and in those with…”
Get full text

Percutaneous radiofrequency ablation for hepatocellular carcinoma: clinical outcome and safety in elderly patients by Nishikawa, Hiroki, Osaki, Yukio, Iguchi, Eriko, Takeda, Haruhiko, Ohara, Yoshiaki, Sakamoto, Azusa, Hatamaru, Keiichi, Henmi, Shinichiro, Saito, Sumio, Nasu, Akihiro, Kita, Ryuichi, Kimura, Toru

“…We aimed to compare clinical outcomes and safety of radiofrequency ablation (RFA) in single hepatocellular carcinoma (HCC) patients aged > 75 years (elderly…”
Get more information

Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experience by ENDO, MASATSUGU, NISHIKAWA, HIROKI, KITA, RYUICHI, KIMURA, TORU, OHARA, YOSHIAKI, SAKAMOTO, AZUSA, SAITO, SUMIO, NISHIJIMA, NORIHIRO, NASU, AKIHIRO, KOMEKADO, HIDEYUKI, OSAKI, YUKIO

“…To the best of our knowledge, none of the prognostic staging systems for hepatocellular carcinoma (HCC) patients who underwent sorafenib therapy is universally…”
Get full text

Impact of pretreatment serum cholinesterase level in unresectable advanced hepatocellular carcinoma patients treated with sorafenib by TAKEDA, HARUHIKO, NISHIKAWA, HIROKI, IGUCHI, ERIKO, OHARA, YOSHIAKI, SAKAMOTO, AZUSA, HATAMARU, KEIICHI, HENMI, SHINICHIRO, SAITO, SUMIO, NASU, AKIHIRO, KOMEKADO, HIDEYUKI, KITA, RYUICHI, KIMURA, TORU, OSAKI, YUKIO

“…The value of serum cholinesterase (ChE) level as a predictive marker in sorafenib therapy for advanced hepatocellular carcinoma (HCC) has not yet been…”
Get full text